Recova Pharma Expo Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
as on 16-11-2024
- Paid Up Capital ₹ 1.10 M
as on 16-11-2024
- Company Age 18 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 12.80 Cr
as on 16-11-2024
- Satisfied Charges ₹ 9.90 Cr
as on 16-11-2024
- Revenue 5.18%
(FY 2023)
- Profit 794.45%
(FY 2023)
- Ebitda -1884.43%
(FY 2023)
- Net Worth 5.30%
(FY 2023)
- Total Assets 6.43%
(FY 2023)
About Recova Pharma Expo
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 1.10 M.
The company currently has active open charges totaling ₹12.80 Cr. The company has closed loans amounting to ₹9.90 Cr, as per Ministry of Corporate Affairs (MCA) records.
Naresh Goel, Ramesh Goel, and Gyanesh Jeswal serve as directors at the Company.
- CIN/LLPIN
U99999DL2006PTC147727
- Company No.
147727
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Mar 2006
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Recova Pharma Expo Private Limited offer?
Recova Pharma Expo Private Limited offers a wide range of products and services, including Pharmaceutical Medicine, Pharmaceutical Drug, Antiseptic Gel, Lotion & Cream, Povidone Iodine Ointment, Antiparasitic Drug, Albendazole Tablets, Anti Allergic Drug, Allergy Relief Tablets.
Who are the key members and board of directors at Recova Pharma Expo?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Naresh Goel  | Director | 20-Mar-2006 | Current |
| Ramesh Goel | Director | 27-May-2014 | Current |
| Gyanesh Jeswal | Director | 23-Jul-2007 | Current |
Financial Performance and Corporate Structure Insights of Recova Pharma Expo.
Recova Pharma Expo Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 5.18% increase. The company also saw a substantial improvement in profitability, with a 794.45% increase in profit. The company's net worth moved up by a moderate rise of 5.3%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Recova Pharma Expo?
In 2023, Recova Pharma Expo had a promoter holding of 25.00% and a public holding of 75.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Warner India Lifesciences LimitedActive 13 years 3 months
Naresh Goel and Gyanesh Jeswal are mutual person
- Sentosa Geigy (India) Labs LimitedActive 14 years 10 months
Naresh Goel and Ramesh Goel are mutual person
- Shrish Enterprises Private LimitedActive 24 years 8 months
Naresh Goel and Ramesh Goel are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 29 Oct 2024 | ₹10.00 Cr | Open |
Axis Bank Limited Creation Date: 18 Apr 2022 | ₹8.00 M | Open |
Axis Bank Limited Creation Date: 23 Mar 2021 | ₹2.00 Cr | Open |
How Many Employees Work at Recova Pharma Expo?
Recova Pharma Expo has a workforce of 2 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Recova Pharma Expo, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Recova Pharma Expo's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
